Bloomage Biotechnology Corp Ltd (688363) — Net Asset Quality Index
Bloomage Biotechnology Corp Ltd (688363) has a Net Asset Quality Index of 81.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥8.75 Billion minus total liabilities of CN¥1.59 Billion yields net assets of CN¥7.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Bloomage Biotechnology Corp Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bloomage Biotechnology Corp Ltd Net Asset Quality Index Over Time (2012–2025)
This chart shows how Bloomage Biotechnology Corp Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 81.8%, representing net assets of CN¥7.16 Billion against total assets of CN¥8.75 Billion CNY. For live market cap and overall valuation, see how much is Bloomage Biotechnology Corp Ltd worth.
Annual Net Asset Quality Index for Bloomage Biotechnology Corp Ltd (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Bloomage Biotechnology Corp Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Bloomage Biotechnology Corp Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.9% | CN¥7.12 Billion | CN¥8.69 Billion | CN¥1.58 Billion | ▲ +2.8 pp |
| 2024 | 79.0% | CN¥6.84 Billion | CN¥8.66 Billion | CN¥1.82 Billion | ▼ -3.4 pp |
| 2023 | 82.4% | CN¥6.98 Billion | CN¥8.47 Billion | CN¥1.49 Billion | ▲ +5.5 pp |
| 2022 | 77.0% | CN¥6.68 Billion | CN¥8.68 Billion | CN¥2.00 Billion | ▲ +1.0 pp |
| 2021 | 76.0% | CN¥5.70 Billion | CN¥7.50 Billion | CN¥1.80 Billion | ▼ -13.1 pp |
| 2020 | 89.1% | CN¥5.09 Billion | CN¥5.72 Billion | CN¥622.68 Million | ▼ -2.4 pp |
| 2019 | 91.5% | CN¥4.55 Billion | CN¥4.97 Billion | CN¥422.11 Million | ▲ +8.6 pp |
| 2018 | 82.9% | CN¥1.72 Billion | CN¥2.07 Billion | CN¥353.56 Million | ▼ -4.0 pp |
| 2017 | 87.0% | CN¥1.64 Billion | CN¥1.88 Billion | CN¥245.35 Million | ▲ +12.1 pp |
| 2016 | 74.9% | CN¥1.26 Billion | CN¥1.68 Billion | CN¥423.53 Million | ▲ +20.7 pp |
| 2015 | 54.2% | CN¥1.19 Billion | CN¥2.20 Billion | CN¥1.01 Billion | ▼ -23.7 pp |
| 2014 | 77.9% | CN¥752.51 Million | CN¥965.44 Million | CN¥212.94 Million | ▲ +4.5 pp |
| 2013 | 73.5% | CN¥564.35 Million | CN¥768.31 Million | CN¥203.96 Million | ▼ -6.0 pp |
| 2012 | 79.5% | CN¥376.97 Million | CN¥474.26 Million | CN¥97.29 Million | — |